Austco Healthcare increases revenues by 29%, invests further in sales capability and declares a fully franked dividend
-
Revenue from customers up 29% to $20.5 million
-
Software and SMA revenues up 47% to $3.6 million
-
Gross Margins increased to 54.8% compared to 52.9% in pcp
-
Underlying EBIT (excluding other income) up 49% to $1.7 million
-
Underlying NPAT (excluding other income) up 57% to $1.3 million
-
Reported NPAT down 9% to $1.4 million
-
Fully franked dividend of 0.175 cents per share declared
Austco Healthcare Limited (ASX:AHC), a global leader in clinical communications solutions, announces a 29% increase in revenue from customers over the prior comparative period (pcp) to $20.5 million for 1HFY23.
Whilst supply chain issues remain and are expected to remain throughout calendar 2023, we noted improvements, especially during the second quarter. The supply chain improvements allowed the Company to accelerate product deliveries on its Open Sales Order book, which gave rise to all regions posting revenue growth. Despite the material increase in revenues, our Open Sales Order book remains robust at $20.3 million (at mid February 2023).
For more information, download the attached PDF.
Download this document
